Latimer Brook Pharmaceutical Consultants East Lyme, CT - 06333

Latimer Brook Pharmaceutical Consultants is categorized under Business Consultants in East Lyme, CT and active since 2009.

Latimer Brook Pharmaceutical Consultants was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Business Consultants business, which does work in the B2B market, and is classified as a Business Consultants, under code number 541618 by the NAICS.

If you are seeking more information, feel free to contact Ethan S Weiner at the company’s single location by writing to 20 Chapman Drive, East Lyme, Connecticut CT 06333 or by phoning (860) 739-9405. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Latimer Brook Pharmaceutical Consultants
Contact Person: Ethan S Weiner
Address: 20 Chapman Drive, East Lyme, Connecticut 06333
Phone Number: (860) 739-9405
Annual Revenue (USD): $100.000 to $499.999
Founded: 2009
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Business Consultants
SIC Code: 8748
NAICS Code: 541618
Share This Business:

Latimer Brook Pharmaceutical Consultants was started in 2009 to provide professional Business Consultants under the SIC code 8748 and NAICS code 541618. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Ethan S Weiner for inquiries that concern Latimer Brook Pharmaceutical Consultants by calling the company number (860) 739-9405, as your correspondence is most welcome. Additionally, the physical location of the single location of Latimer Brook Pharmaceutical Consultants can be found at the coordinates 41.409935,-72.219725 as well as the street address 20 Chapman Drive in East Lyme, Connecticut 06333.

For its online presence, you may visit Latimer Brook Pharmaceutical Consultants’s website at and engage with its social media outlets through on Twitter and on Facebook.